The congressional letter addressed to FDA Acting Commissioner Kyle Dimantas highlights growing concerns regarding public health and consumer confusion. Lawmakers argue that allowing plant-based alternatives to co-opt established dairy terminology misleads shoppers into assuming non-dairy beverages carry equivalent nutritional profiles. Pointing to warnings from health organizations like the American Academy of Pediatrics, the coalition emphasizes that most plant-based substitutes (with the exception of fortified soy) fall significantly short in essential nutrient density compared to real cow’s milk.

This executive pressure aligns directly with Senator Baldwin’s landmark legislative initiative, the bipartisan Defending Against Imitations and Replacements of Yogurt, milk, and cheese to Promote Regular Intake of Dairy Everyday (DAIRY PRIDE) Act. The proposed bill would legally mandate that the FDA take administrative action against misbranded food products under Section 403 of the Federal Food, Drug, and Cosmetic Act, explicitly establishing that non-dairy products cannot utilize standardized dairy nomenclature.

The bipartisan group explicitly urges the current administration to do what previous regulators failed to do by officially rescinding past, permissive FDA draft guidance. Industry advocates point out that while dairy producers must comply with rigorous, federally enforced quality and production standards to use the label “milk,” plant-based manufacturers face no such requirement while enjoying the commercial equity built by the real dairy sector.